Mainz Biomed N.V. Ordinary Shares

MYNZ XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

11M

Short interest (Feb 13)

2.7%

Net Short (Mar 11 ): 0.0%

Borrow Fee

9.35%

Available Shares

30K

Price Chart

Company Overview

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Company Info

Exchange: NASDAQ

CIK: 0001874252

Asset Type: CS

Market Data

Market Cap: $10,564,195

Employees: 26

Status: Active

Short Interest

Current Borrow Fee 9.35%

Range: 8.23% - 9.60%

Available Shares 30K

Range: 20K - 200K

Recent Changes

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime